Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vapocoolant Spray for IV Insertion Pain
NCT03054740Phase 4Completed
- Sponsor
- Aultman Health Foundation
- Start
- Feb 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethyl chloride in procedural pain, sponsored by Aultman Health Foundation. Started Feb 2017; status: completed.
02
Drugs
ethyl chloride
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03054740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054740.